DDOG Form 144 shows Olivier Pomel sale, 32,923 Class A shares valued at $4.31M

Rhea-AI Filing Summary

This Form 144 notifies a proposed sale of 32,923 shares of Class A Common stock of Datadog (DDOG) on NASDAQ, with an aggregate market value of $4,309,949.93 and shares outstanding listed as 323,270,704. The filing lists the acquisition source for the shares to be sold: 21,728 shares were acquired the same day by exercise of stock options and paid for in cash, while 11,195 are noted as founders shares from 07/08/2010.

The notice also records multiple recent sales by the same account under 10b5-1 plans and direct sale entries in June and July 2025, including individual transactions of 100,754, 107,365, 21,728, and other blocks with the listed gross proceeds. The filer represents that, by signing, they are not aware of undisclosed material adverse information about the issuer.

Positive

• Proposed sale is clearly disclosed with exact share count and aggregate market value
• Acquisition sources are specified (option exercise and founders shares), including payment method for the exercised shares
• Multiple prior 10b5-1 plan sales are listed, providing visibility into recent insider transactions

Negative

• Insider has multiple recent sales disclosed in June–July 2025, including large blocks of 100,754 and 107,365 shares
• Proposed sale of 32,923 shares ($4.31M) adds to several recent dispositions by the same account

Insights

Financial Analyst

TL;DR Insider disclosure shows a modest proposed sale and a string of recent 10b5-1 plan transactions totaling multiple large blocks in June–July 2025.

The Form 144 reports a proposed sale of 32,923 Class A shares valued at $4.31M and documents the specific acquisition sources: 21,728 shares from an option exercise paid in cash and 11,195 founders shares. The filing also lists several 10b5-1 plan sales and a direct sale by the named individual, with each transaction showing dates, share amounts, and gross proceeds. For investors, this is a routine insider sale disclosure; the numbers are explicit but represent a small fraction of the 323,270,704 shares outstanding.

Corporate Governance Expert

TL;DR The filing documents transparent insider sales and references 10b5-1 trading plans and an option exercise as the source of shares.

The notice identifies the seller by name in the transaction history and specifies that some sales occurred under 10b5-1 plans while the proposed block includes shares from a same-day option exercise paid in cash. The remarks section reiterates the signer’s representation about absence of undisclosed material adverse information, which is standard. This disclosure aligns with procedural requirements for reporting proposed insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32923	4309949.93	323270704	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Exercise of Stock Options	Issuer			21728	08/11/2025	Cash
Common	07/08/2010	Founders Shares	Issuer			11195	07/08/2010	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	07/28/2025	11195	1688462.37
10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	07/08/2025	21728	3173448.28
10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	07/08/2025	11196	1635065.71
10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/25/2025	100754	13286953.90
10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/09/2025	107365	13067743.08
OLIVIER POMEL 620 8th Avenue, 45th Floor New York NY 10018	Class A Common	06/02/2025	15227	1779137.91

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Datadog (DDOG) Form 144 report?

The filing reports a proposed sale of 32,923 Class A Common shares on NASDAQ with an aggregate market value of $4,309,949.93.

Who is identified in the transaction history on the Form 144?

The transaction history names Olivier Pomel in 10b5-1 plan entries and a direct sale entry; the filing lists sales associated with that account.

What were the sources of the shares to be sold?

The table shows 21,728 shares acquired by exercise of stock options (paid in cash) on 08/11/2025 and 11,195 as founders shares from 07/08/2010.

Were there recent insider sales reported before this proposed sale?

Yes. The filing lists multiple sales in June–July 2025 under 10b5-1 plans and direct entries, including transactions of 100,754 and 107,365 shares with stated gross proceeds.

On which exchange is the proposed sale expected to occur?

The Form 144 lists NASDAQ as the securities exchange for the proposed sale.

Does the filer make any representation about material information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.